ORKA Oruka Therapeutics Earnings and EPS analysis

Relative Growth: Rel. Growth: 0

Relative Strength: Rel. Strength: 99

Relative Valuation: Rel. Valuation: N/A

Relative Profitability: Rel. Profitability: 8

EPS in 2026 (TTM): -$2.03

Last Report Period Date: Jun 30, 2026

Based on the company's latest reports for June 2026, the current 12-month EPS is -$2.03. Oruka Therapeutics's earnings per share in 2025 was reported at -$1.85, marking a rise from -$3.87 in 2024. In the quarterly report ending on Jun 30, 2026, ORKA's earnings per share amounted to -$0.55.

ORKA earnings history

Historical annual and quarterly earnings per share (EPS) data for Oruka Therapeutics

EPS (TTM)

-$2.03

EPS Growth YoY (Quarterly)

-19.6%

EPS (Quarterly)

-$0.55

EPS Growth (Quarterly)

-14.6%

Oruka Therapeutics had an yealy earnings per share of -$1.85, showing a rise of 52.2% from -$3.87 recorded in 2024. The quarterly earnings per share for the period ending Jun 30, 2026, was -$0.55, showing a 19.6% decline compared to the same quarter last year. The trailing twelve months EPS for ORKA is -$2.03 as of June 2026. Oruka Therapeutics's full-year EPS for 2024 was -$3.87, a 12.8% rise compared to the previous year.

ORKA EPS vs price chart

ORKA EPS growth history

Earnings per share growth rates over time

EPS Growth YoY (Quarterly)

-19.6%

EPS growth YoY

52.2%

EPS growth 3Y avg

N/A

EPS growth 5Y avg

N/A

In the past 12 months, Oruka Therapeutics has recorded an earnings per share growth rate of -19.6% (YoY, quarterly).

ORKA Earnings Waterfall

Breakdown of revenue, profit and net income for Oruka Therapeutics

ORKA Earnings vs Peers

What are the earnings of ORKA compared to its peers

Stock name	Price to Earnings	EPS grwoth 1Y	EPS grwoth 3Y	EPS grwoth 5Y
UTHR UNITED THERAPEUTICS Corp	16.58	14%	23.5%	20.9%
MDT Medtronic Plc	24.15	3.3%	9.8%	6.9%
CYTK Cytokinetics Inc	N/A	-24.3%	N/A	N/A
ORKA Oruka Therapeutics Inc.	N/A	52.2%	N/A	N/A

All data is based on quarterly TTM periods, unless otherwise specified.